Capital Advisors, Ltd. LLC Relay Therapeutics, Inc. Transaction History
Capital Advisors, Ltd. LLC
- $767 Million
- Q1 2024
A detailed history of Capital Advisors, Ltd. LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 92 shares of RLAY stock, worth $585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92
Previous 87
5.75%
Holding current value
$585
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RLAY
# of Institutions
188Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$177 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$75.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$62.3 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$47.2 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$43.8 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $765M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...